Clinical Trials in Houston

Showing 12181-12200 of 17,885 trials

Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00006471

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of fenretinide in treating patients who have recurrent or metastatic head and neck cancer.

Head and Neck Cancer

M.D. Anderson Cancer Center11 participantsStarted Sep 2000

Houston, Texas, United States

COMPLETEDNA< 1 mile

rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin

NCT00038012

A Pilot Study of Transfusion of rhTPO-Derived Autologous Platelets Cryopreserved with ThromboSol and 2% DMSO in Patients with Gynecologic Malignancy Receiving Carboplatin

Neoplasms, Gynecologic

M.D. Anderson Cancer Center33 participantsStarted Jul 1999

Houston, Texas, United States

TERMINATEDPhase 2< 1 mile

Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas

NCT00038701

The goal is to assess survival and patterns of failure in patients treated with Gemzar-based chemoradiation and TNP-470 for locally advanced adenocarcinoma of the pancreas.

Pancreatic Neoplasms

M.D. Anderson Cancer Center6 participantsStarted Aug 1999

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

NCT00002855

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining hormone therapy with chemotherapy and androgen suppression may kill more tumor cells. It is not yet known which treatment regimen is more effective for prostate cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy plus hormone therapy versus androgen suppression alone as initial therapy in patients with prostate cancer that is metastatic or that cannot be removed surgically.

Prostate Cancer

M.D. Anderson Cancer Center306 participantsStarted Aug 1996

Houston, Texas, United States

Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin

Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

Find Trials by Condition in Houston

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Imatinib Mesylate in Treating Patients With Metastatic Melanoma

Houston Independent School District (HISD) Yoga Evaluation

Thalidomide-Dexamethasone for Multiple Myeloma

Study of Gelonin Purging of Autologous Stem Cells for Transplantation

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

XprESS Eustachian Tube Dilation Study

The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment

Validation Study of the SAGIT® Instrument in Acromegaly

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.